Escitalopram Oxalate
Product Images NDC 70934-089

This is a label of a medication, Escitalopram in the form of tablets. It comes in a 90-tablet bottle with a strength of 20mg and requires a prescription. It has an NDC number of 70934-089-90 and was repackaged by Northwind Pharmaceuticals. The medication should be stored at room temperature. The label contains information about the lot number, expiration date, and manufacturing date.*

This is a table that lists the observed treatment-emergent adverse reactions for Escitalopram Oxalate compared to Placebo in patients with Major Depressive Disorder. The reactions are grouped by category such as Autonomic Nervous System Disorders, Central and Peripheral Nervous System, Gastrointestinal Disorders, Psychiatric Disorders, Respiratory System Disorders, and Urogenital. The table also includes the percentage of patients who experienced each reaction, with a minimum threshold of >2% and greater than placebo. The reactions that meet these criteria include dry mouth, sweating increased, dizziness, nausea, diarrhea, constipation, influenza-like symptoms, fatigue, insomnia, somnolence, appetite decreased, libido decreased, rhinitis, sinusitis, ejaculation disorder, impotence, and anorgasmia. Some additional notes are included at the end of the table discussing the denominator used for males and females for certain reactions.*

This is a table presenting the adverse reactions observed during the treatment for Generalized Anxiety Disorder. The adverse reactions with a frequency of more than 2% and greater than placebo are listed. The table presents the percentage of adverse reaction of Escitalopram and Placebo separately. The adverse reactions are listed as per different body systems. The adverse reactions that are common and have greater than 2% frequency are Nausea, Dry Mouth, Headache, Insomnia, Sweating Increased, Ejaculation Disorder, and Fatigue.*